# CCI-779 in Treating Patients With Metastatic Melanoma

> **NCT00022464** · PHASE2 · COMPLETED · sponsor: **City of Hope Medical Center**

## Conditions studied

- Melanoma (Skin)

## Interventions

- **DRUG:** temsirolimus

## Key facts

- **NCT ID:** NCT00022464
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** — (—)
- **Last updated:** 2015-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00022464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00022464, "CCI-779 in Treating Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00022464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*